Catha edulis, a plant that has amphetamine effects

Pharmacy World and Science

Volumn 18, Issue 2, 1996, Pages 69-73

  Kalix, Peter ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Catha edulis; cathinone; drug habit; khat; stimulant

Indexed keywords

ALKALOID; AMPHETAMINE; CATHINONE; PSYCHOSTIMULANT AGENT;

ADRENERGIC ACTIVITY; CATHA EDULIS; DRUG EFFECT; DRUG INFORMATION; DRUG MECHANISM; HABIT; HUMAN; MASTICATION; NONHUMAN; PLANT; SHORT SURVEY; SOCIAL ASPECT;

ALKALOIDS; APPETITE DEPRESSANTS; CATHA; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; PHENYLPROPANOLAMINE; PLANT EXTRACTS;

EID: 0029967396     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00579708     Document Type: Short Survey

References (39)

1. LeBras M, Frétillère Y. Les aspects médicaux de la consommation habituelle du khat. Méd Trop 1965; 25: 720-732.
2. Weir S. Qat in Yemen, consumption and social change. 1985; British Museum Publications, London, United Kingdom.
3. Pantelis C, Hindler C, Taylor J. Use and abuse of khat: distribution, pharmacology, side effects and description of psychosis attributed to khat chewing. Psychol Med 1989; 19: 657-6898.
4. Eddy N, Halbach H, Isbell H, Seevers M. Drug dependence, its significance and characteristics. Bull WHO 1965; 32: 721-733.
5. Halbach H. Medical aspects of the chewing of khat leaves. Bull WHO 1972; 47: 21-29.
6. Luqman W, Danowski T. The use of khat in Yemen: social and medical observations. Ann Intern Med 1976; 85: 246-249.
7. Kennedy J, Teague J, Fairbanks I. Qat use in North Yemen and the problem of addiction: a study in medical anthropology. Cult Med Psychiat 1980; 4: 311-344.
8. World Health Organisation. Expert Committee on addiction-producing drugs: khat. WHO Technol Rep Ser 1964; 273: 10.
9. Wolfes O. Uber das Vorkommen von D-nor-iso-Ephedrin in Catha edulis. Arch Pharm (Weinheim) 1930; 268: 81-83.
10. Schorno X, Steinegger E. CNS-active phenylpropylamines of Catha edulis of Kenyan origin. Experientia 1979; 35: 572-574.
11. Alles G, Fairchild D, Jensen M. Chemical pharmacology of Catha edulis. J Med Pharm Chem 1961; 3: 323-352.
12. Hofmann H, Opitz K, Schnelle H. Die Wirkung des Norpseudoephedrins. Arzneim-Forsch 1955; 5: 367-370.
13. Winterfeld K, Bernsmann G. Zur Kenntnis der Inhaltsstoffe von Catha edulis. Arch Pharm 1960; 63: 991-1000.
14. Brücke F. Uber die zentralerregende Wirkung des Alkaloides Cathin. Arch Exp Pathol Pharmakol 1941; 198: 100-106.
15. Paris M, Moyse H. Essai de caractérisation du kat, drogue récemment inscrite au tableau B. Ann Pharm Fr 1967; 15: 89-97.
16. Rücker G, Kröger H, Schikarski M, Qédan S. Uber die Alkaloide aus Catha edulis. Planta Med 1971; 24: 61-65.
17. Friebel H, Brilla R. Uber den Wirkstoff der frischen Blätter und Zweigspitzen von Catha edulis. Naturwissenschaften 193; 50: 354-355.
18. Szendrei K. The chemistry of khat. Bull Narc 1980; 32: 5-36.
19. United Nations. Etudes sur la composition chimique du khat: Recherches sur la fraction phenylalkylamine. UN document MNAR/11/1975.
20. Schorno X, Brenneisen R, Steinegger E. Qualitative und quantitative Untersuchungen uber das Vorkommen ZNS-aktiver Phenylpropylamine in Handelsdrogen und über deren Verteilung in verschiedenen Organen von Catha edulis. Pharm Acta Helv 1982; 57: 168-176.
21. Geisshüsler S, Brenneisen R. The content of psychoactive phenylpropyl- and phenylpentenyl-khatamines in Catha edulis Forsk of different origin. J Ethnopharmac 1987; 19: 269-277.
22. World Health Organisation. WHO Advisory Group: Review of the pharmacology of khat. Bull Narc 1980; 32: 89-93.
23. Galkin V, Mironychev A. Effect of the narcotic khat (Catha edulis) on certain functions of the human body. Fedn Proc 1964; 23: T741-742.
24. Valterio C, Kalix P. The effect of the alkaloid cathinone on the motor activity of mice. Arch Int Pharmacodyn Thér 1982; 255: 196-203.
25. Foltin R, Schuster C. Behavioral tolerance and cross-tolerance to DL-cathinone and D-amphetamine in rats. J Pharmac exp Ther 1982; 222: 126-131.
26. Kalix P, Glennon R. Further evidence for an amphetamine-like mechanism of action of the alkaloid cathinone. Biochem Pharmac 1986; 35: 3015-3019.
27. Johanson C, Schuster C. A comparison of the behavioral effects of L- and DL-cathinone and D-amphetamine. J Pharmac exp Ther 1981; 219: 355-362.
28. Yanagita T. Intravenous self-administration of cathinone and of 2-amino-1-(2,5-dimethoxy-4-methyl-)phenylpropane in rhesus monkeys. Drug Alcohol Depend 1986; 17: 135-141.
29. Van der Schoot J, Ariens E, Van Rossum J, Hurkmans J. Phenylisopropylamine derivatives: Structure and action. Arzneim-Forsch 1962; 12: 902-907.
30. Brenneisen R, Fisch HU, Koelbing U, Geisshüsler S, Kalix P. Amphetaime-like effects in humans of the khat alkaloid cathinone. Br J Clin Pharmac 1990; 30: 825-828.
31. Widler P, Mathys K, Brenneisen R, Kalix P, Fisch HU. Pharmacodynamics and pharmacokinetics of khat: a controlled study. Clin Pharmac Ther 1994; 55: 556-562.
32. Kalix P. The amphetamine-like releasing effect of the alkaloid cathinone on rat nucleus accumbens and rabbit caudate nucleus. Prog Neuropsychopharmac biol Psychiat 1982; 6: 43-49.
33. Pehek E, Schlechter M, Yamamoto B. Effects of cathinone and amphetamine on the neurochemistry of dopamine in vivo. Neuropharmacology 1990; 29: 1171-1176.
34. Kalix P. Pharmalogical properties of the stimulant khat. Pharmac Ther 1990; 48: 397-416.
35. Gold M, Bowers M. Neurobiological vulnerability to low-dose amphetamine psychosis. Am J Psychiatry 1978; 135: 1546-1548.
36. Gendron Y, Ardouin C, Martine J. Accidents cardiovasculaires aigus déclenchés par le khat. Méd Trop 1977; 37: 69-73.
37. Mayberry J, Morgan G, Perkin E. Khat-induced schizophreniform psychosis in UK. Lancet 1984; 8374: 455.
38. Nencini P, Grassi M, Botan A, Asseyr A, Paroli E. Khat chewing spread to the Somali community in Rome. Drug Alcohol Depend 1989; 23: 255-258.
39. Browne D. Qat use in New York City. NIDA Research Monograph 1990; 105: 464-465.